Related Experiment Video
Updated: Feb 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Treatment of Hypertension in Chronic Kidney Disease
Rigas G Kalaitzidis1, Moses S Elisaf2
1Department of Nephrology, University Hospital of Ioannina, 455 00, Ioannina, Greece. rigaska@gmail.com.
Insights
Managing hypertension in chronic kidney disease (CKD) involves a blood pressure goal below 130/80 mmHg. Key treatments include ACE inhibitors, ARBs, and diuretics, with CCBs used cautiously.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Chronic kidney disease (CKD) is a global health issue.
- Hypertension is a common comorbidity that worsens with declining kidney function.
Purpose of the Study:
- To review current treatment options for hypertension in CKD patients.
- To highlight updated hypertension guidelines for CKD management.
Main Methods:
- Review of current hypertension guidelines.
- Analysis of antihypertensive medication classes for CKD patients.
Main Results:
- Updated guidelines recommend a blood pressure goal < 130/80 mmHg for CKD patients.
- Angiotensin-converting enzyme (ACE) inhibitors are first-line agents, with Angiotensin II receptor blockers (ARBs) as alternatives.
- Non-dihydropyridine calcium channel blockers (CCBs) reduce albuminuria; dihydropyridine CCBs require combination therapy with RAAS blockers.
Conclusions:
- Intensive blood pressure control is crucial for CKD patients.
- A stepwise approach using ACE inhibitors/ARBs, diuretics, and CCBs is recommended.
- Lifestyle modifications and pharmacotherapy are essential for managing hypertension in CKD.
Purpose Of Review:
Chronic kidney disease (CKD) is recognized as a worldwide epidemic. Hypertension commonly coexists with CKD and its prevalence is progressively increasing as kidney function declines.
Recent Findings:
For patients with established CKD and/or diabetes with albuminuria, the updated hypertension guidelines have recommended a blood pressure (BP) goal < 130/80 mmHg. Blood pressure level above 130/80 mmHg in CKD patients requires lifestyle modifications and multiple antihypertensive medications. According to recent guidelines, angiotensin-converting enzyme (ACE) inhibitors should be the drugs of first choice. Angiotensin II receptor blockers (ARBs) should be used if the ACE inhibitor is not tolerated. Non-dihydropyridine CCBs consistently reduce albuminuria and slow the decline in kidney function. Dihydropyridine CCBs should not be used as monotherapy in proteinuric CKD patients but always in combination with a RAAS blocker. Diuretics are commonly used and represent the cornerstone in the management of CKD patients. All the other agents are used when treatment with the other primary agents have failed. In patients with CKD, an intensive BP goal < 130/80 mmHg has been recommended. We review current treatment options.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
02:34Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment